BIIB Financial Facts

Net income: 856.12M
Other income (expense), net: -16.29M
See Full Income Statement

Long-term deferred tax liability: 90.36M
Preferred stock, par value $0.001 per share: 0
See Full Balance Sheet

Biogen Idec Inc. (BIIB) Earnings

  |   Expand Research on BIIB
Next EPS Date 4/24/15 EPS Growth Rate +58.3%
Average EPS % Beat Rate +9.4% Revenue Growth Rate +26.7%
Average % Move 1-Wk after EPS +4.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/24/15 Q115 N/A$3.91 N/A N/A$2.66B = N/A N/A
4/23/14 Q114 $2.47$2.56 -$0.09$2.1B$2B Details
5/1/12 Q112 $1.40$1.48 -$0.08$1.29B$1.31B = Details
1/28/13 Q412 $1.40$1.46 -$0.06$1.4B$1.38B Details
7/26/11 Q211 $1.36$1.37 -$0.01$1.21B$1.18B = Details
1/31/12 Q411 $1.51$1.49 +$0.02$1.3B$1.29B = Details
4/21/11 Q111 $1.43$1.41 +$0.02$1.2M$1.18B = Details
1/29/14 Q413 $2.34$2.27 +$0.07$2B$1.93B Details